Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
The panelists examine the CheckMate-67T study, which evaluated the efficacy and safety of subcutaneous versus intravenous administration of nivolumab in patients with previously treated advanced or metastatic clear cell renal cell carcinoma.
The progression-free survival benefit with belzutifan was observed across subgroups of patients with pretreated advanced clear cell renal cell carcinoma.
Robert Uzzo, MD, MBA, FACS, discusses a biomarker analysis of the IMmotion010 trial in patients with renal cell carcinoma.
Preliminary experience in guiding individualized targeted therapy of advanced metastatic renal cell carcinoma with gene detection technology.
Patients receiving immune checkpoint inhibitors for renal cell carcinoma had improved symptom burden when enrolled in a remote exercise program.
Rashad Nawfal, MD, discusses radiological tumor burden as an independent prognostic factor for survival in metastatic clear cell renal cell carcinoma.
A retrospective study sought to assess CRS and ICANS onset and duration, as well as non-relapse mortality causes in patients infused with CAR T-cell therapies.
The following is a summary of “Influence of cryoablation versus operation on circulating lymphocyte subsets in patients with early-stage renal cell...
Anti CD70 antibodies hold significant therapeutic potential in the treatment of various cancers due to their ability to target CD70 a protein selectively expressed on the surface of several tumor cells This targeted approach allows for the precise destruction of ...
Nazli Dizman, MD, discusses the impact of CBM588 on gut microbiome composition in patients with renal cell carcinoma who received immune checkpoint inhibitors in the first line.
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.